From the Food and Drug Administration.
Nightingale
S L
SL
D000890:Anti-Infective Agents / Q000009:adverse effects*; D003195:Computer Communication Networks; D003257:Consumer Product Safety; D004348:Drug Labeling; D004797:Enzyme-Linked Immunosorbent Assay; D024841:Fluoroquinolones; D015483:HIV Antibodies / Q000652:urine*; D015658:HIV Infections / Q000175:diagnosis* / Q000652:urine; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D011639:Public Opinion; D052256:Tendinopathy / Q000139:chemically induced*; D013708:Tendon Injuries / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015483:HIV Antibodies